RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Validation of the Functional assessment of cancer therapy-Breast Symptom Index (FBSI)
Yost, KJ., Yount, SE., Eton, DT., Silberman, C., Heyes, A., & Cella, D. (2005). Validation of the Functional assessment of cancer therapy-Breast Symptom Index (FBSI). Breast Cancer Research and Treatment, 90(3), 295-298. https://doi.org/10.1007/s10549-004-5024-3
We assessed the reliability, validity, and responsiveness to change of the 6-item Functional Assessment of Cancer Therapy-Breast Symptom Index (FBSI) in a sample of 615 metastatic breast cancer patients. The FBSI is a brief, clinically relevant, and psychometrically sound instrument that can be used to measure symptoms in patients with breast cancer.
RTI shares its evidence-based research - through peer-reviewed publications and media - to ensure that it is accessible for others to build on, in line with our mission and scientific standards.